《血液学杂志》.2005年.第10期
......
- Immunomodulatory derivative of thalidomide(IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting
- High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced folli
- Hereditary hemochromatosis is reflected in the iron isotope composition of blood
- Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leu
- PIG-A mutations in normal hematopoiesis
- CCAAT/enhancer binding protein : changes in function upon phosphorylation by p38 MAP kinase
- Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656
- NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses
- Tie2Cre-mediated gene ablation defines the stem-cell leukemia gene(SCL/tal1)–dependent window during hematopoietic stem-cell development
- Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B
- Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants
- Urokinase-type plasminogen activator is a preferred substrate of the human epithelium serine protease tryptase /PRSS22
- Thrombopoietin initiates demethylation-based transcription of GP6 during megakaryocyte differentiation
- Rapid ubiquitination of Syk following GPVI activation in platelets
- Transmembrane CEACAM1 affects integrin-dependent signaling and regulates extracellular matrix protein–specific morphology and migration of e
- Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma
- Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells
- Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international c
- Plasma membrane sequestration of apoptotic protease-activating factor-1 in human B-lymphoma cells: a novel mechanism of chemoresistance
- Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients
- In vitro functional analysis of human ferroportin(FPN) and hemochromatosis-associated FPN mutations
- Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibr
- Protein-4.2 association with band 3(AE1, SLCA4) in Xenopus oocytes: effects of three natural protein-4.2 mutations associated with hemolyti
- Trafficking of the major virulence factor to the surface of transfected P falciparum–infected erythrocytes
- Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patie
- Hepcidin in iron overload disorders
- NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A
- Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation
- Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells
- SCL/Tal-1 is essential for hematopoietic commitment of the hemangioblast but not for its development
- Positive and negative regulation of c-Myb by cyclin D1, cyclin-dependent kinases, and p27 Kip1
- WHO-EORTC classification for cutaneous lymphomas
- The actin cytoskeleton differentially regulates platelet -granule and dense-granule secretion
- New trends in umbilical cord blood transplantation
- Membrane type 1–matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibrone
- Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells
- Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor
- Deficiency in the p110 subunit of PI3K results in diminished Tie2 expression and Tie2-/-–like vascular defects in mice
- Activation of Src kinase Lyn by the Kaposi sarcoma–associated herpesvirus K1 protein: implications for lymphomagenesis
- Expression of the human germinal center–associated lymphoma(HGAL) protein, a new marker of germinal center B-cell derivation
- An anti-CD20–IL-2 immunocytokine is highly efficacious in a SCID mouse model of established human B lymphoma
- Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells
- Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and
- Vitamin C protects HL60 and U266 cells from arsenic toxicity
- PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid l
- Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells
- Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD
- The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus pro
- Synergistic interactions between imatinib mesylate and the novel phosphoinositide-dependent kinase-1 inhibitor OSU-03012 in overcoming imati